HENRY SCHEIN, INC. Deferred Foreign Income Tax Expense (Benefit)
HENRY SCHEIN, INC. (HSIC) reported Deferred Foreign Income Tax Expense (Benefit) of -$31.00 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-24
- HENRY SCHEIN, INC. deferred foreign income tax expense (benefit) for fiscal 2025 was -$31.00M.
- HENRY SCHEIN, INC. deferred foreign income tax expense (benefit) for fiscal 2024 was -$20.00M.
- HENRY SCHEIN, INC. deferred foreign income tax expense (benefit) for fiscal 2023 was -$26.00M.
- HENRY SCHEIN, INC. deferred foreign income tax expense (benefit) for fiscal 2022 was -$12.00M, a 400.00% decline from fiscal 2021.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month | Deferred Foreign Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-27 | -$31.00M 10-K · filed 2026-02-24 | |
| 2024-12-28 | -$20.00M 10-K · filed 2026-02-24 | |
| 2023-12-30 | -$26.00M 10-K · filed 2026-02-24 | |
| 2022-12-31 | -$12.00M 10-K · filed 2025-02-25 | |
| 2021-12-25 | $4.00M 10-K · filed 2024-02-28 | $3.70M 10-K · filed 2022-02-15 |
| 2020-12-26 | -$30.00M 10-K · filed 2023-02-21 | -$30.06M 10-K · filed 2021-02-17 |
| 2019-12-28 | -$11.29M 10-K · filed 2022-02-15 | |
| 2018-12-29 | -$23.97M 10-K · filed 2021-02-17 | -$27.26M 10-K · filed 2019-02-20 |
| 2017-12-30 | -$13.36M 10-K · filed 2020-02-20 | -$14.06M 10-K · filed 2018-02-21 |
| 2016-12-31 | -$14.17M 10-K · filed 2019-02-20 | |
| 2015-12-26 | -$3.85M 10-K · filed 2018-02-21 | |
| 2014-12-27 | $3.98M 10-K · filed 2017-02-21 | |
| 2013-12-28 | -$17.31M 10-K · filed 2016-02-10 | |
| 2012-12-29 | -$116.00K 10-K · filed 2015-02-11 | |
| 2011-12-31 | -$5.07M 10-K · filed 2014-02-11 | |
| 2010-12-25 | $4.34M 10-K · filed 2013-02-13 | |
| 2009-12-26 | -$20.40M 10-K · filed 2012-02-15 | |
| 2008-12-27 | -$627.00K 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ (ACH) | United States | $0.057B | -0.87 |